Expect to See Saxenda Used for Weight Loss in Adolescents

May 2021

Saxenda (liraglutide) will be a new option to help tackle obesity in adolescents 12 and up...not just in adults.

About 30% of Canadian kids age 5 to 17 are overweight or obese. This may lead to adulthood obesity and a higher risk of health conditions...type 2 diabetes, heart disease, sleep apnea, etc.

The injectable med Saxenda has the same active ingredient as the diabetes med, Victoza. The big difference is that Saxenda is given in higher doses than Victoza...to help reduce hunger.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

COVID-19 Listen for Concerns About Blood Clots With COVID-19 Vaccines
COVID-19 Implement Guardrails to Prevent COVID-19 Vaccine Errors
Immunizations Encourage Patients to Protect Their COVID-19 Vaccination Card
Medication Errors Clarify Questionable Combo Med Rxs
Lyme Disease Be Prepared to Dispense Antibiotics for Lyme Disease
Hypertension Avoid Mishaps With Thiazide Diuretics
Pediatrics Expect to See Saxenda Used for Weight Loss in Adolescents
Practice Career Ladders Can Help You Move Up to Advanced Roles
Migraine Understand Proper Use of Triptans for Acute Migraine

Expect to See Saxenda Used for Weight Loss in Adolescents

Practical advice for a better career, with unlimited access to CE

Table of Contents